Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms

Life Sciences

Volumn 80, Issue 15, 2007, Pages 1388-1394

  Tsunematsu, Masako ^a   Yamaji, Taketo ^a   Kozutsumi, Daisuke ^a   Murakami, Rika ^a   Kimura, Shigeki ^a   Kino, Kohsuke ^a  

^a MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Allergic rhinitis; Cry j 1; Histamine; Murine model

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CRY J 1 ANTIGEN; DEXAMETHASONE; EOSINOPHIL PEROXIDASE; EPITOPE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; KETOTIFEN FUMARATE; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; DISEASE MODEL; ENZYME ACTIVITY; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN PRODUCTION; MOUSE; MOUSE STRAIN; NONHUMAN; NOSE MUCOSA; PROVOCATION TEST; SENSITIZATION; SNEEZING; SYMPTOMATOLOGY; T LYMPHOCYTE;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIGENS; CRYPTOMERIA; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HISTAMINE; IMMUNIZATION; IMMUNOGLOBULIN E; KETOTIFEN; MICE; NASAL MUCOSA; PEROXIDASES; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SNEEZING;

ANIMALIA; CRYPTOMERIA JAPONICA; MURINAE; MUS; RHODOCOCCUS RHODOCHROUS;

EID: 33847686688     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.12.038     Document Type: Article

References (31)

1. Bochner B.S., and Busse W.W. Allergy and asthma. Journal of Allergy and Clinical Immunology 115 5 (2005) 953-959
2. Caramori G., and Adcock I. Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. Current Drug Targets. Inflammation and Allergy 4 4 (2005) 455-463
3. Ciprandi G., Cirillo I., Vizzaccaro A., Milanese M., and Tosca M.A. Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow. International Archives of Allergy and Immunology 134 1 (2004) 34-40
4. Connell J.T. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. The Journal of Allergy 43 1 (1969) 33-44
5. Donald Y.M., and Leung M.D. Pathogenesis of atopic dermatitis. Journal of Allergy and Clinical Immunology 104 (1999) S99-S108
6. Fukuda S., Midoro K., Gyoten M., Kawano Y., Ashida Y., Nabe T., Kohno S., and Nagaya H. Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis. European Journal of Pharmacology 476 3 (2003) 239-247
7. Grant S.M., Goa K.L., Fitton A., and Sorkin E.M. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40 3 (1990) 412-448
8. Hashimoto M., Nigi H., Sakaguchi M., Inouye S., Imaoka K., Miyazawa H., Taniguchi Y., Kurimoto M., Yasueda H., and Ogawa T. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. European Journal of Pharmacology 25 9 (1995) 848-852
9. Horak F., and Stubner P. New trends in allergic rhinitis. Allergy and Clinical Immunology International 10 3 (1998) 81-87
10. Igarashi Y., Goldrich M.S., Kaliner M.A., Irani A.M., Schwartz L.B., and White M.V. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. Journal of Allergy and Clinical Immunology 95 (1995) 716-725
11. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., and Akdis C.A. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 6854 (2001) 420-425
12. Jutel M., Blaser K., and Akdis C.A. Histamine in allergic inflammation and immune modulation. International Archives of Allergy and Immunology 137 1 (2005) 82-92
13. Kawaguchi S., Ukai K., Jin C.S., and Sakakura Y. Effect of histamine on nasal epithelial permeability to horseradish peroxidase in allergic guinea pigs. Annals of Otology, Rhinology & Laryngology 104 5 (1995) 394-398
14. Kim J.H., Mun Y.J., Ahn S.H., Park J.S., and Woo W.H. Induction of oral tolerance to Japanese cedar pollen. Archives of Pharmacal Research 24 6 (2001) 557-563
15. Kingetsu I., and Saito S. Identical recognition of T-cell epitopes by Th1 and Th2 subsets in mice immunized with Japanese cedar pollen antigens. Jikeikai Medical Journal 45 (1998) 95-105
16. Kingetsu I., Ohno N., Hayashi N., Sakaguchi M., Inouye, and Saito S. Common antigenicity between Japanese cedar (Cryptomeria japonica) pollen and Japanese cypress (Chamaecyparis obtusa) pollen, I. H-2 complex affects cross responsiveness to Cry j 1 and Cha o 1 at the T- and B-cell level in mice. Immunology 99 4 (2000) 625-629
17. Komiyama N., Sone T., Shimizu K., Morikubo K., and Kino K. cDNA cloning and expression of Cry j II the second major allergen of Japanese cedar pollen. Biochemical and Biophysical Research Communications 201 2 (1994) 1021-1028
18. Miadonna A., Milazzo N., Gibelli S., Salmaso C., Lorini M., and Tedeschi A. Nasal response to a single antigen challenge in patients with allergic rhinitis- inflammatory cell recruitment persists up to 48 hours. European Journal of Pharmacology 29 7 (1999) 941-949
19. Murasugi T., Nakagami Y., Yoshitomi T., Hirahara K., Yamashita M., Taniguchi Y., Sakaguchi M., and Ito K. Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice. European Journal of Pharmacology 510 (2005) 143-148
20. Nabe T., Mizutani N., Shimizu K., Takenaka H., and Kohno S. Development of pollen-induced allergic rhinitis with early and late phase nasal blockage in guinea pigs. Inflammation Research 47 9 (1998) 369-374
21. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Annals of Allergy, Asthma and Immunology 91 3 (2003) 288-296
22. Sato J., Asakura K., Murakami M., Uede T., and Kataura A. Topical CTLA4-Ig suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis. International Archives of Allergy and Immunology 119 3 (1999) 197-204
23. Savage J., and Roy D. Allergic rhinitis: an update. Journal of the Royal Society of Health 125 4 (2005) 172-175
24. Sone T., Komiyama N., Shimizu K., Kusakabe T., Morikubo K., and Kino K. Cloning and sequencing of cDNA coding for Cry j I, a major allergen of Japanese cedar pollen. Biochemical and Biophysical Research Communications 199 2 (1994) 619-625
25. Sone T., Morikubo K., Miyahara M., Komiyama N., Shimizu K., Tsunoo H., and Kino K. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. Journal of Immunology 161 1 (1998) 448-457
26. Sugimoto Y., Kawamoto E., Chen Z., and Kamei C. A new model of allergic rhinitis in rats by topical sensitization and evaluation of H(1)-receptor antagonists. Immunopharmacology 48 1 (2000) 1-7
27. Takeuchi K., Kishioka C., Ishinaga H., Sakakura Y., and Majima Y. Histamine alters gene expression in cultured human nasal epithelial cells. Journal of Allergy and Clinical Immunology 107 2 (2001) 310-314
28. Tamura S., Kobayashi T., Kikuta K., Nakagawa M., Sakaguchi M., and Inouye S. IgE antibody responses against Japanese cedar pollen in the mouse. Microbiology and Immunology 30 9 (1986) 883-891
29. Terada N., Konno A., and Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. Journal of Allergy and Clinical Immunology 94 (1994) 629-642
30. Yamasaki M., Mizutani N., Sasaki K., Nabe T., Matsumoto T., Ashida Y., and Kohno S. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflammation Research 50 9 (2001) 466-473
31. Yasueda H., Yui Y., Shimizu T., and Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. Journal of Allergy and Clinical Immunology 71 (1983) 77-86